Form D Explorer
ZETAGEN THERAPEUTICS, INC. · CIK 1730728

Citable research briefCompare issuerPrivate research collection

ZETAGEN THERAPEUTICS, INC.

CIK 1730728 · Corporation · Inc. DELAWARE · SYRACUSE, NY · Pharmaceuticals
Sign up to follow
Filings
2
Original notices
1
Amendments
1
Activity
Jan 23, 2025
through Nov 12, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJan 23, 2025 · DNov 12, 2025 · D/ALater minus earlier
Reported offering amount$6,173,828$12,999,998$6,826,170
Reported amount sold$83,186$12,908,022$12,824,836
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001730728-25-000001 · Later SEC source: 0001730728-25-000003

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D/A · Nov 12, 2025

Reported offering amount
$12,999,998
Reported amount sold
$12,908,022

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Contact info

Log in to look up an email or website for this issuer.

Form D filings (2)